Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778856 · ClinicalTrials.gov registry record · NA
Hand Transplantation for the Reconstruction of Below the Elbow Amputations
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00778856 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 19 participants.
The verdict
NCT00778856, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Organ transplantation has become the treatment of choice for most patients suffering end stage diseases of the kidney, pancreas, liver, heart or lung. Vascularized Composite Allotransplantation (VCA) {a.k.a. composite tissue allotransplantation} is the term used to describe transplantation of multiple tissues (skin, muscle, bone, cartilage, nerve, tendon, vessel) as a functional unit (e.g. hand). Several recent advances in clinical organ transplant immunosuppression and experimental limb VCA have now made it feasible to consider clinical VCA for the functional restoration of patients with loss of one or both hands. This protocol facilitates the development of limb VCA at the Atlanta Veterans Affairs Medical Center (VAMC) and at Emory University for patients with below the elbow amputations. It will evaluate the patients' use of transplanted limb(s) in activities of daily living and compare the function of the transplanted hand to the function with their previous prosthesis. Patients with below the elbow amputations will be enrolled. Donor tissue will be recovered from deceased donors following the guidelines of and in cooperation with the regional Organ Procurement Organization. The transplantation procedure and postoperative care will be performed using the standard technique for limb replantation. Patients will receive standard immunosuppressive regimen. Rejections will be treated in keeping with experience from the solid organ transplant experience. Graft failure will be treated with allograft amputation.
Interventions
- PROCEDURE Hand transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00778856
The ClinicalTrials.gov registry entry for NCT00778856 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hand transplantation is the first listed.
NCT00778856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00778856 about?
NCT00778856 is a clinical study titled "Hand Transplantation for the Reconstruction of Below the Elbow Amputations". Organ transplantation has become the treatment of choice for most patients suffering end stage diseases of the kidney, pancreas, liver, heart or lung. Vascularized Composite Allotransplantation (VCA) {a.k.a. composite tissue allotransplantation} is the term used to describe transplantation of multi...
What is the current status of trial NCT00778856?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2008-09. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00778856?
The interventions under investigation include: Hand transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00778856?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.